These drugs alter insulin signaling, digestion, and appetite suppression by slowing gastric emptying and changing how quickly food moves through the gastrointestinal tract
Dosing frequency and pharmacokinetic profile play crucial roles in gastrointestinal tolerability
Kevin Sheng-Kai Ma, DDS, FRSPH, FRSM, international scholar at the Center for Global Health at the Perelman School of Medicine at the University of Pennsylvania and lead author of this study, told Medical News Today that he and his colleagues were not surprised by these findings, as these [obesity and obesity-related issues] are indications for GLP-1RA that have been approved in recent years. That said, clinicians are encouraged to monitor and continue assessing patients receiving GLP-1RA [drugs], he advised
Caution should be taken against the promising marketing strategies of GLP-1 patches, like fat reduction without lifestyle modification
True Value Score: B Lab Testing: What Gets Measured and Why It Matters WeightWatchers providers may order baseline labs before starting your GLP-1 treatment to confirm the medication is safe and appropriate for you